BNTX US09075V1026

Report

Delayed Nasdaq - 01/21 04:00:00 pm
147.5	USD		-5.77%

01/21	Boosters provide 'added protection' against Omicron -CDC	RE
01/21	Small children getting less sick from Omicron; Genetic mutation protects against severe COVID	RE
01/21	U.S. studies highlight the need for COVID boosters to fight Omicron	RE

Calendar

Event chart BIONTECH SE

Upcoming events on BIONTECH SE

04/05/22		FY 2021 Earnings Release (Projected)
05/17/22		Q1 2022 Earnings Release (Projected)
08/16/22		Interim 2022 Earnings Release (Projected)
11/16/22		Q3 2022 Earnings Release (Projected)

Past events on BIONTECH SE

01/11/22 \| 09:45am		JP Morgan Healthcare Conference
12/17/21 \| 05:20am		Berenberg Corporate Conference
12/08/21 \| 09:00am		International digital press conference
11/30/21 \| 11:45am		Evercore ISI HealthCONx Conference
11/17/21 \| 09:15am		Cowen IO Next Summit
11/17/21		Wolfe Research Healthcare Conference
11/16/21		Jefferies London Healthcare Conference
11/13/21 \| 12:45pm		Society for immunotherapy of cancer meeting - abstract no: 493
11/13/21 \| 07:00am		Society for immunotherapy of cancer meeting - abstract no: 786
11/13/21 \| 07:00am		Society for immunotherapy of cancer meeting - abstract no: 516

Past dividends on BIONTECH SE

- No events available -

Annual results

Fiscal Period : December		2019	2020	2021
Sales M €	Released Forecast Spread	109 110 -1,6%	482 432 12%	17 454
Operating income (EBITDA) M €	Released Forecast Spread	-148 -145 -1,9%	-43,7 -287 85%	13 866
Operating profit (EBIT) M €	Released Forecast Spread	-182 -167 -8,7%	-82,4 -306 73%	13 564
Pre-Tax Profit (EBT) M €	Released Forecast Spread	-179 -158 -14%	-146 -325 55%	12 956
Net income M €	Released Forecast Spread	-179 -157 -14%	15,2 -336 105%	9 220
EPS €	Released Forecast Spread	-0,85 -0,74 -15%	0,06 -1,44 104%	36,7
Announcement Date		03/31/2020	03/30/2021	-

Quarterly results

Fiscal Period : December

2020 Q3

2020 Q4

2021 Q1

2021 Q2

2021 Q3

2021 Q4

Sales
M €

Released
Forecast
Spread

67,5
51,7
30%

345
190
82%

2 048
1 793
14%

5 309
3 274
62%

6 087
5 020
21%

4 166

Operating income
(EBITDA)
M €

Released
Forecast
Spread

-178
-72,4
-145%

257
-199
229%

1 675
1 385
21%

4 215
2 528
67%

4 743
3 000
58%

2 750

Operating profit
(EBIT)
M €

Released
Forecast
Spread

-186
-92,6
-101%

244
-24,6
1 091%

1 662
986
69%

4 198
2 554
64%

4 724
3 968
19%

3 040

Pre-Tax Profit
(EBT)
M €

Released
Forecast
Spread

-208
-73,6
-182%

206
-57,2
460%

1 642
1 379
19%

4 023
2 637
53%

4 667
3 309
41%

2 475

Net income
M €

Released
Forecast
Spread

-210
-90,0
-133%

367
-59,0
722%

1 128
778
45%

2 787
1 784
56%

3 211
2 671
20%

1 926

EPS
€

Released
Forecast
Spread

-0,88
-0,41
-114%

1,57
-0,16
1 111%

4,39
3,09
42%

10,8
6,94
55%

12,4
10,4
19%

7,99

Announcement Date

11/10/2020

03/30/2021

05/10/2021

08/09/2021

11/09/2021

Previous year

Next Year

Upcoming sector events for BIONTECH SE

02/02/22		VERTEX PHARMACEUTICALS :
02/04/22		REGENERON PHARMACEUTICALS, INC. :
02/08/22		GILEAD SCIENCES, INC. :
03/30/22		WUXI APPTEC CO., LTD. :
04/28/22		VERTEX PHARMACEUTICALS :
05/03/22		WUXI APPTEC CO., LTD. :
05/03/22		GILEAD SCIENCES, INC. :
05/05/22		REGENERON PHARMACEUTICALS :
07/27/22		VERTEX PHARMACEUTICALS INCORPORATED :
07/27/22		GILEAD SCIENCES, INC. :

More events

Past sector events for BIONTECH SE

11/04/21 \| 05:30am		REGENERON PHARMACEUTICALS, INC. :
11/02/21 \| 03:01pm		VERTEX PHARMACEUTICALS INCORPORATED :
10/29/21 \| 05:41am		WUXI APPTEC CO., LTD. :
10/28/21 \| 04:02pm		GILEAD SCIENCES, INC. :
08/12/21 \| 05:52am		WUXI APPTEC CO., LTD. :
08/05/21 \| 06:30am		REGENERON PHARMACEUTICALS, INC. :
07/29/21 \| 04:01pm		GILEAD SCIENCES, INC. :
07/29/21 \| 04:01pm		VERTEX PHARMACEUTICALS INCORPORATED :
05/06/21 \| 06:30am		REGENERON PHARMACEUTICALS :
04/29/21 \| 04:01pm		VERTEX PHARMACEUTICALS :

More events

Analysis

German economy short of pre-pandemic level despite 2.7% growth in 2021